See the DrugPatentWatch profile for Helixate
What is Helixate FS?
Helixate FS is a brand of recombinant coagulation factor VIII used to treat or prevent bleeding in people with hemophilia A (factor VIII deficiency). It helps replace the missing factor so blood can clot. [1]
How is Helixate FS used?
Helixate FS is given as an injection. Patients are typically dosed based on the individual’s factor VIII level, the severity of bleeding, and the goal (prevention vs treatment of bleeding episodes). [1]
What kinds of bleeding does it help with?
Like other factor VIII replacement therapies, Helixate FS is used for both:
- Treating bleeding episodes
- Preventing bleeding (prophylaxis), depending on the patient’s regimen [1]
Are there important safety or patient concerns?
Common practical concerns with factor VIII products include the need for correct dosing and monitoring to maintain adequate factor VIII levels. People with hemophilia A also need monitoring for development of inhibitors (antibodies) that can make factor VIII less effective, which is a key issue across hemophilia A therapies. [1]
How does Helixate FS compare to other factor VIII products?
Helixate FS is one of several recombinant factor VIII options. Differences among products usually involve manufacturing process, dosing schedules, and how long the factor VIII lasts in the body (half-life), which affects how often injections are needed. [1]
Where can you find prescribing information?
You can review dosing, indications, contraindications, and safety details in the official prescribing information for Helixate FS. [1]
Sources
- Helixate FS (recombinant factor VIII) prescribing information and labeling